Palatin Technologies
PTN
#10523
Rank
HK$0.16 B
Marketcap
HK$90.90
Share price
12.20%
Change (1 day)
12,770.06%
Change (1 year)

Palatin Technologies (PTN) - Total debt

Total debt on the balance sheet as of September 2025 : HK$1.03 Million

According to Palatin Technologies's latest financial reports the company's total debt is HK$1.03 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Palatin Technologies - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2025-06-30HK$1.28 M-72.11%
2024-06-30HK$4.6 M-44.01%
2023-06-30HK$8.23 M-9.06%
2022-06-30HK$9.05 M-6.89%
2021-06-30HK$9.72 M-0.91%
2020-06-30HK$9.81 M277.35%
2019-06-30HK$2.6 M-94.73%
2018-06-30HK$49.3 M-55.28%
2017-06-30HK$0.11 B-27.23%
2016-06-30HK$0.15 B98.45%
2015-06-30HK$76.33 M
2014-06-30N/A-100%
2013-06-30HK$0.15 M-52.82%
2012-06-30HK$0.32 M-45.46%
2011-06-30HK$0.6 M126.91%
2010-06-30HK$0.26 M-71.94%
2009-06-30HK$0.94 M-68.58%
2008-06-30HK$3 M-21.98%
2007-06-30HK$3.84 M56.59%
2006-06-30HK$2.45 M946.31%
2005-06-30HK$0.23 M-52.75%
2004-06-30HK$0.49 M-75.91%
2003-06-30HK$2.06 M
2001-06-30HK$0.21 M
1999-06-30HK$15.51 M122.44%
1998-06-30HK$6.97 M-49.99%
1997-06-30HK$13.94 M-44.66%
1996-06-30HK$25.19 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$431.26 B 41,516,442.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$266.01 B 25,608,827.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$3.18 B 306,591.03%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
HK$1.41 M 36.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$3.54 B 341,153.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$4.81 B 463,303.95%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
HK$1.63 B 157,144.46%๐Ÿ‡บ๐Ÿ‡ธ USA